ADVM - Adverum Biotechnologies Stock Trading

Adverum Biotechnologies Inc.(NASDAQ: ADVM) stock trading, description, contact, officers and directors.

About Adverum Biotechnologies Inc.

Not available

Stock Information

Adverum Biotechnologies Inc. Company Name:

ADVM Stock Symbol:

NASDAQ Market:

Get ADVM Alerts

News, Short Squeeze, Breakout and More Instantly...

RECENT ADVM NEWS

ADVM - Adverum Biotechnologies: Keep On Your Watchlist In 2020

Today, we will study why Adverum Biotechnologies ( ADVM ) is a promising gene player in 2020. Company overview Adverum Biotechnologies is a clinical-stage gene therapy company focused on ocular and rare diseases. The company is evaluating its lead asset, ADVM-022 in wet AMD (age-related ...
ADVM - Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook

-- OPTIC phase 1 trial progressing with plans to complete patient dosing in cohort three, begin enrollment in cohort four in 1Q20 -- -- IND application planned for ADVM-022 in diabetic retinopathy in 1H20; Patient enrollment targeted for 2H20 -- MENLO PARK, Calif., Jan. 12, 2020 (G...
ADVM - Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the Atlantic Coast Retina Club Macula 20/20 Annual Meeting

--44 week median follow up for patients (n=6)-- --Zero anti-VEGF rescue injections required following intravitreal ADVM-022; First patient has reached 52-weeks post treatment-- --Vision remains stable and anatomical improvements maintained-- MENLO PARK, Calif., Jan. 11, 2020 (GLOBE ...